Don't miss Verge's CSO Robert Scannevin at the BIO Investor Forum

Don't miss Verge's CSO Robert Scannevin at the BIO Investor Forum, IO Investor Forum, where he'll join other biotech leaders in a panel discussion. Watch to learn about the use of biomarkers in the clinical development of therapies for neurodegenerative diseases and hear how Verge is leveraging the CONVERGE® Platform to develop therapeutics for complex diseases.